Expression of cytokines in the gingival crevicular fluid and serum from patients with inflammatory bowel disease and untreated chronic periodontitis

Journal of Periodontal Research

Volumn 46, Issue 1, 2011, Pages 141-146

  Da Silva Figueredo, C M ^a,b   Brito, F ^a   Barros, F C ^a   Menegat, J S B ^a   Pedreira, R R ^a   Fischer, R G ^a   Gustafsson, A ^b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Crohn's disease; Cytokine; Inflammatory bowel disease; Periodontitis; Ulcerative colitis

Indexed keywords

CYTOKINE; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CHEMISTRY; CHRONIC PERIODONTITIS; ENTERITIS; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERIODONTAL POCKET; PILOT STUDY;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; CYTOKINES; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKINS; MALE; MIDDLE AGED; PERIODONTAL POCKET; PILOT PROJECTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650883772     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2010.01303.x     Document Type: Article

References (35)

1. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004;35:21-41.
2. Yücel OO, Berker E, Gariboǧlu S, Otlu H. Interleukin-11, interleukin-1 beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol 2008;35:365-370.
3. Zhong Y, Slade GD, Beck JD, Offenbacher S. Gingival crevicular fluid interleukin-1beta, prostaglandin E2 and periodontal status in a communitypopulation. J Clin Periodontol 2007;34:285-293.
4. Figueredo CM, Ribeiro MS, Fischer RG, Gustafsson A. Increased interleukin-1beta concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol 1999;70:1457-1463.
5. Engebretson S, Chertog R, Nichols A, Hey-Hadavi J, Celenti R, Grbic J. Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. J Clin Periodontol 2007;34:18-24.
6. Ikezawa I, Tai H, Shimada Y, Komatsu Y, Galicia JC, Yoshie H. Imbalance between soluble tumour necrosis factor receptors type 1 and 2 in chronic periodontitis. J Clin Periodontol 2005;32:1047-1054.
7. Figueredo CM, Rescala B, Teles RP et al. Increased interleukin-18 in gingival crevicular fluid from periodontitis patients. Oral Microbiol Immunol 2008;23:173-176.
8. Orozco A, Gemmell E, Bickel M, Seymour GJ. Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol 2006;21:256-260.
9. Pradeep AR, Roopa Y, Swati PP. Interleukin-4, a T-helper 2 cell cytokine, is associated with the remission of periodontal disease. J Periodontal Res 2008;43:712-716.
10. Ejeil AL, Gaultier F, Igondjo-Tchen S et al. Are cytokines linked to collagen breakdown during periodontal disease progression? J Periodontol 2003;74:196-201.
11. Flemmig TF, Shanahan F, Miyasaki KT. Prevalence and severity of periodontal disease in patients with inflammatory bowel disease. J Clin Periodontol 1991;18:690-697.
12. Grössner-Schreiber B, Fetter T, Hedderich J, Kocher T, Schreiber S, Jepsen S. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol 2006;33:478-484.
13. Brito F, de Barros FC, Zaltman C et al. Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis. J Clin Periodontol 2008;35:555-560.
14. Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007;102:2058-2069.
15. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-533.
16. Mudter J, Neurath MF. Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 2007;13:1016-1023.
17. Ardizzone S, Bianchi Porro G. Biologic therapy for inflammatory bowel disease. Drugs 2005;6:2253-2286.
18. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
19. Salvi GE, Brown CE, Fujihashi K et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res 1998;33:212-225.
20. Bozkurt FY, Yetkin Ay Z, Berker E, Tepe E, Akkuş S. Anti-inflammatory cytokines in gingival crevicular fluid in patients with periodontitis and rheumatoid arthritis: a preliminary report. Cytokine 2006;35:180-185.
21. Todaro M, Lombardo Y, Francipane MG et al. Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ 2008;15(4):762-772.
22. Aoudjehane L, Pissaia A Jr, Scatton O et al. Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway. Lab Invest 2008;88:973-985.
23. Ludwiczek O, Kaser A, Novick D, Dinarello CA, Rubinstein M, Tilg H. Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease. Eur Cytokine Netw 2005;16:27-33.
24. Furuya D, Yagihashi A, Komatsu M et al. Serum interleukin-18 concentrations in patients with inflammatory bowel disease. J Immunother 2002;25(Suppl 1):S65-S67.
25. Kanai T, Watanabe M, Okazawa A et al. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease. Gastroenterology 2000;119:1514-1523.
26. Wiercinska-Drapalo A, Flisiak R, Jaroszewicz J, Prokopowicz D. Plasma interleukin-18 reflects severity of ulcerative colitis. World J Gastroenterol 2005;11:605-608.
27. Naftali T, Novick D, Gabay G, Rubinstein M, Novis B. Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation. Isr Med Assoc J 2007;9:504-508.
28. Novick D, Schwartsburd B, Pinkus R et al. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 2001;14:334-342.
29. Gracie JA, Forsey RJ, Chan WL et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-1401.
30. Tsutsui H, Nakanishi K, Matsui K et al. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996;157:3967-3973.
31. Mizel SB. Interleukin 1 and T cell activation. Immunol Rev 1982;63:51-72.
32. Schmidt JA, Mizel SB, Cohen D, Green I. Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol 1982;128:2177-2182.
33. Gowen M, Mundy GR. Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro. J Immunol 1986;136:2478-2482.
34. Switalla S, Lauenstein L, Prenzler F et al. Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices. Toxicol Appl Pharmacol 2010;Apr 29. Epub ahead of print.
35. Heasman L, Stacey F, Preshaw PM, McCracken GI, Hepburn S, Heasman PA. The effect of smoking on periodontal treatment response: a review of clinical evidence. J Clin Periodontol 2006;33(4):241-253.